couter

OGIOrganigram Global Inc.

Oct 15, 2026 — Canadian Excise Tax Policy & Regulatory Update
Chart by TradingView

The schedule

  • Thu15Oct

    Expected updates on potential Canadian excise tax reform, a critical catalyst for domestic cannabis margins.

  • Thu15Apr

    Assessment of broader sector sentiment as US federal policy stalls, limiting cross-border M&A optionality.

  • Wed12May

    Year-end financial results with a focus on potential inventory impairments and cash runway.

  • Wed11Aug

    First quarter fiscal 2027 results, where capital preservation and potential dilution will be front and center.

Past

  • Wed12Aug

    Actual outcome: Bull · $1.23 at outcome

    Organigram reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, driven by the consolidation of its Sanity Group acquisition and improved performance in Canadian cannabis categories. Although the company posted a net loss that met consensus estimates, the strong top-line growth and positive EBITDA trajectory overshadowed the bottom-line deficit, keeping the stock trading well above the bull target.

    Next scheduled quarterly earnings release amid ongoing negative revenue growth and cash burn.

  • Thu9Jul

    Actual outcome: Bear · $0.86 at outcome

    Organigram reported Q3 2026 earnings with an EPS of -$0.007, exactly in line with consensus estimates. The stock remained flat following the release, as the anticipated earnings and cash flow update provided no new surprises or catalysts to drive a material breakout in either direction.

    Organigram reported Q3 2026 earnings with an EPS of -$0.007, exactly in line with consensus estimates. The stock remained flat following the release, as the anticipated earnings and cash flow update provided no new surprises or catalysts to drive a material breakout in either direction.

Scouting Reports